FDA Approved: NIZATIDINE — Supplemental Application (Epic Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental application for nizatidine from Epic Pharma, LLC (ANDA 076178). This marks approval of a supplemental update for this generic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer
• Gastroesophageal Reflux Disease

Drugs mentioned

• Nizatidine (nizatidine)

Snippet

SUPPL AP for NIZATIDINE (NIZATIDINE)